The system will be designed to treat post-amputation pain. The system will feature SPR’s proprietary method of percutaneously stimulating peripheral nerves. This involves the insertion of a very small medical wire or lead through the skin.
This NIH grant adds to a $2.8 million research grant from the U.S. Department of Defense for ongoing clinical trials that assess the safety and efficacy of SPR Therapeutics’ PNS therapy.
More articles on anesthesia:
Annual & hourly anesthesiologist pay: 8 statistics
Somnia Anesthesia calls for anesthesiologist of the year award nominations
Dr. Julian Gold named mayor of California’s Beverly Hills
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
